Amaral, A. T., Garofalo, C., Frapolli, R., Manara, M. C., Mancarella, C., Uboldi, S., . . . Scotlandi, K. (2015). Trabectedin efficacy in Ewing sarcoma Is greatly increased by combination with anti-IGF signaling agents.
Citación estilo ChicagoAmaral, Ana Teresa, et al. Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased By Combination With Anti-IGF Signaling Agents. 2015.
Cita MLAAmaral, Ana Teresa, et al. Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased By Combination With Anti-IGF Signaling Agents. 2015.
Precaución: Estas citas no son 100% exactas.